Frequent Infections: When to See a Doctor and What It Could Mean

What Counts as "Frequent" Infections

Two colds per winter does not qualify. The Jeffrey Modell Foundation diagnostic criteria, endorsed by the American Academy of Allergy, Asthma and Immunology, define warning signs for primary immunodeficiency (PID) as four or more new ear infections in one year, two or more serious sinus infections in one year, two or more months on antibiotics with little effect, two or more pneumonias within 12 months, or a need for intravenous antibiotics to clear infections [1].

These thresholds exist because the immune system has built-in redundancy. A single missed cold season or one stubborn sinus infection rarely indicates systemic failure. The pattern matters more than any single episode.

For urinary tract infections, the European Association of Urology defines recurrence as three or more symptomatic, culture-confirmed UTIs in 12 months or two episodes within six months [2]. Recurrent vulvovaginal candidiasis is defined as four or more episodes per year [3]. Each organ system has its own frequency cutoff because baseline infection rates differ by site.

The 2022 Global Burden of Disease study estimated that lower respiratory infections alone caused 2.18 million deaths worldwide that year, making infection frequency a clinical signal worth tracking rather than dismissing as "just bad luck" [4].

Why You Keep Getting Sick: The Major Causes

The causes of recurrent infection split into two broad categories. Primary immunodeficiencies are genetic. Secondary immunodeficiencies are acquired. Both are more common than most patients realize.

Primary Immunodeficiency

The Jeffrey Modell Foundation estimates that 1 in 1,200 people in the United States lives with a primary immunodeficiency disorder, yet the average diagnostic delay stretches 6 to 15 years [1]. Common variable immunodeficiency (CVID) is the most frequently diagnosed symptomatic PID in adults, affecting roughly 1 in 25,000 to 1 in 50,000 people. CVID patients have low IgG and at least one other low immunoglobulin class, producing poor vaccine responses and recurrent sinopulmonary infections [5].

Dr. Charlotte Cunningham-Rundles, who directs the Immunodeficiency Clinic at Mount Sinai, has stated: "Many patients with CVID see five or more physicians over a decade before the correct diagnosis is made. A simple blood test measuring immunoglobulin levels could have identified the problem years earlier" [5].

Selective IgA deficiency is even more common (1 in 300 to 1 in 500 people) but is usually asymptomatic. When it does cause recurrent mucosal infections, it may overlap with IgG subclass deficiency [6].

Secondary (Acquired) Immunodeficiency

This category is far larger. The causes include:

Uncontrolled diabetes. A 2021 meta-analysis in The Lancet Diabetes & Endocrinology (N=18 cohort studies, 12.4 million participants) found that individuals with HbA1c above 8% had a 2.0-fold increased risk of bacterial skin infections and a 1.8-fold increased risk of urinary tract infections compared to those with HbA1c below 7% [7]. Hyperglycemia impairs neutrophil chemotaxis, phagocytosis, and oxidative burst.

Medications. Corticosteroids at doses equivalent to prednisone 10 mg/day or higher for more than three weeks suppress cellular immunity. Biologic agents (TNF-alpha inhibitors, anti-CD20 antibodies like rituximab) and conventional immunosuppressants (methotrexate, mycophenolate) each carry defined infection risk profiles listed in their FDA prescribing information [8].

Chronic kidney disease. The uremic milieu impairs both innate and adaptive immunity. Infection is the second leading cause of death in dialysis patients, according to the United States Renal Data System [9].

HIV infection. A CD4 count below 200 cells/mm³ defines AIDS, but infection susceptibility rises well before that threshold. Current DHHS guidelines recommend antiretroviral therapy for all people with HIV regardless of CD4 count [10].

Malnutrition and micronutrient deficiencies. Zinc deficiency alone reduces T-cell output. A Cochrane review of 33 trials (N=4,334) found that zinc supplementation reduced the incidence of infections in children and older adults by 19% [11].

Hormonal Contributions

Hormones regulate immune function in ways that clinical practice often overlooks. Estrogen promotes B-cell survival and antibody production. Progesterone modulates T-regulatory cell activity. Testosterone influences neutrophil trafficking and inflammatory cytokine balance.

Postmenopausal women who are not on hormone replacement therapy experience higher rates of recurrent UTIs partly because declining estrogen thins the vaginal and urethral epithelium, shifts the local microbiome away from protective Lactobacillus species, and raises vaginal pH [12]. The American Urological Association recommends vaginal estrogen as first-line prevention for recurrent UTIs in postmenopausal women [2].

In men, hypogonadism (total testosterone below 300 ng/dL) correlates with impaired immune surveillance. A 2019 study in the Journal of Clinical Endocrinology & Metabolism (N=2,161 men, mean follow-up 4.3 years) found that men in the lowest testosterone quartile had a 32% higher rate of hospitalization for infection compared to the highest quartile, after adjusting for age, BMI, and comorbidities [13]. Testosterone replacement in deficient men may restore neutrophil function, though randomized infection-endpoint trials remain limited.

The Diagnostic Workup: What Your Doctor Should Order

A structured evaluation prevents both under-testing and expensive scattershot panels. The European Society for Immunodeficiencies (ESID) recommends a tiered approach [14].

Tier 1: Basic Screening

Every patient with a pattern of recurrent infections should receive:

• Complete blood count with differential. This identifies neutropenia (absolute neutrophil count below 1,500/mm³), lymphopenia (absolute lymphocyte count below 1,000/mm³), and unexpected cytopenias.
• Quantitative immunoglobulins (IgG, IgA, IgM). Low IgG (below 600 mg/dL in adults) is the single most informative screening result.
• Metabolic panel and HbA1c. Uncontrolled diabetes is the most common treatable cause of secondary immunodeficiency in U.S. adults.
• HIV testing. The CDC recommends screening for all adults aged 13 to 64 at least once, and more frequently in those with recurrent infections [10].
• Urinalysis and renal function. CKD stage 3 or higher warrants immune-focused monitoring.

Tier 2: Directed Investigation

If Tier 1 is abnormal or clinical suspicion remains high despite normal results:

• IgG subclass levels (IgG1 through IgG4). Some patients have a normal total IgG but a deficient subclass, particularly IgG2, which handles polysaccharide-encapsulated bacteria like Streptococcus pneumoniae.
• Vaccine response titers. The most specific functional test. Measure antibody titers to tetanus (protein antigen) and pneumococcal serotypes (polysaccharide antigens) before and four weeks after vaccination. Failure to mount a fourfold rise in at least 70% of pneumococcal serotypes tested suggests antibody deficiency even with normal immunoglobulin levels [14].
• Complement levels (CH50, C3, C4). Complement deficiency predisposes to Neisseria infections and autoimmune disease.
• Lymphocyte subset panel (CD3, CD4, CD8, CD19, CD16/56). Maps T-cell, B-cell, and NK-cell populations.

Tier 3: Specialist Referral

Flow cytometry for lymphocyte function, genetic panels for known PID genes (over 480 identified as of 2024), and bone marrow biopsy fall within the scope of clinical immunology [14].

The 2023 ESID Registry report, covering 38,862 patients across 30 countries, found that patients diagnosed within two years of symptom onset had a 45% lower rate of structural lung damage (bronchiectasis) compared to those diagnosed after a delay of more than five years [15]. Speed matters.

When to Worry: Red Flags That Demand Urgent Evaluation

Not every recurrent infection warrants a full immunologic workup. But certain patterns should accelerate referral.

Infections with unusual organisms. Pneumocystis jirovecii pneumonia, disseminated Mycobacterium avium complex, invasive aspergillosis, or recurrent Neisseria meningitidis suggest specific immune defects. These organisms rarely cause disease in immunocompetent hosts.

Deep-seated or organ-threatening infections. A liver abscess, osteomyelitis, or empyema in a patient without an obvious risk factor (recent surgery, IV drug use, indwelling catheter) raises the index of suspicion for neutrophil dysfunction or complement deficiency.

Failure of standard therapy. An infection that does not clear with an appropriate, full-course antibiotic regimen (not a three-day Z-pack for what turns out to be bacterial sinusitis) points to either resistant organisms or impaired host defense.

Family history. A first-degree relative with diagnosed immunodeficiency, unexplained infant death, or autoimmunity increases pretest probability.

Combination with autoimmunity. About 25% of CVID patients also have autoimmune cytopenias (immune thrombocytopenia or autoimmune hemolytic anemia) [5]. Recurrent infections plus autoimmune disease in the same patient is a PID red flag.

Dr. Javier Chinen, associate professor of pediatrics and immunology at Baylor College of Medicine, puts it plainly: "If a patient tells you they have been on antibiotics five or six times in the past year and they are still getting sick, the question is no longer whether to investigate. The question is why you have not investigated already" [1].

Treatment Options Once a Cause Is Found

Treatment depends entirely on the underlying diagnosis. There is no universal "immune booster." Targeted therapy works. Vague supplementation does not.

Immunoglobulin Replacement

For patients with confirmed antibody deficiency (CVID, specific antibody deficiency, XLA), subcutaneous or intravenous immunoglobulin replacement reduces infection frequency by 70% to 85% in prospective cohort data [5]. The typical IgG trough target is above 500 mg/dL, though many immunologists aim for above 700 mg/dL based on data showing fewer breakthrough pneumonias at higher troughs. Treatment is lifelong for genetic deficiencies.

Glycemic Optimization

Bringing HbA1c from 9% to 7% or below measurably reduces infection hospitalization rates within six months. GLP-1 receptor agonists (semaglutide, tirzepatide) not only improve glycemic control but also demonstrate anti-inflammatory effects. The SUSTAIN-6 trial (N=3,297) showed that semaglutide reduced HbA1c by 1.4 percentage points at 104 weeks [16]. While infection endpoints were not the primary outcome, the metabolic improvement is itself protective.

Hormone Optimization

Vaginal estrogen for postmenopausal recurrent UTIs has a number needed to treat (NNT) of approximately 3 to prevent one UTI recurrence over 6 months, per a Cochrane meta-analysis of 3,345 women [12]. Systemic HRT may offer broader immune support through estrogen receptor signaling on monocytes and dendritic cells, though infection-specific randomized data remain limited.

In men with documented hypogonadism (two morning total testosterone levels below 300 ng/dL), testosterone replacement therapy may improve immune cell function. The Testosterone Trials (TTrials, N=790 men aged 65 and older) showed improvements in multiple domains with testosterone gel, and secondary analyses noted trends toward fewer self-reported infections in the treatment arm, though the study was not powered for this endpoint [17].

Prophylactic Antibiotics

For recurrent sinopulmonary infections with confirmed antibody deficiency, some immunologists prescribe rotating prophylactic antibiotics (azithromycin 250 mg three times weekly is a common regimen). This approach requires balancing infection prevention against resistance selection and should be guided by a specialist.

Vaccination Strategy

Paradoxically, patients with some forms of antibody deficiency can still benefit from vaccination. Live vaccines are contraindicated in severe combined immunodeficiency and some other PIDs, but inactivated vaccines (influenza, pneumococcal, COVID-19) are safe and may provide partial protection even in patients with suboptimal antibody responses [14]. Annual influenza vaccination and age-appropriate pneumococcal vaccination remain standard of care.

Lifestyle Factors That Actually Affect Infection Frequency

Evidence supports a short list. Sleep deprivation (fewer than six hours per night) reduced participants' resistance to rhinovirus challenge by 4.2-fold in a Carnegie Mellon quarantine study (N=164) [18]. That is a larger effect size than most supplements claim.

Regular moderate exercise (150 minutes per week of brisk walking) is associated with 40% to 50% fewer upper respiratory infection days compared to sedentary controls in a meta-analysis of 14 randomized trials [19]. Overtraining (marathon-distance running without adequate recovery) has the opposite effect, transiently suppressing mucosal IgA.

Zinc supplementation (15 to 30 mg elemental zinc daily) has the strongest evidence among micronutrients for reducing infection incidence in deficient populations [11]. Vitamin D supplementation (1,000 to 2 to 000 IU daily) reduced acute respiratory infections by 12% overall in an individual participant data meta-analysis of 25 RCTs (N=11,321), with the benefit concentrated in those with baseline 25-hydroxyvitamin D levels below 25 nmol/L [20].

Probiotics containing Lactobacillus rhamnosus GG or Bifidobacterium lactis reduced antibiotic-associated diarrhea in a Cochrane review, but evidence for preventing primary infections in adults remains inconsistent [21].

What to Tell Your Doctor at the First Visit

Bring a written infection log. Include dates, the site of each infection, the antibiotic prescribed, the duration of treatment, and whether the infection fully resolved. This single document is more useful than any test you could order yourself.

Mention all medications, including over-the-counter proton pump inhibitors (which impair gastric acid barrier defense), nasal corticosteroid sprays, and any history of chemotherapy. Note any family history of unusual infections, early death from infection, or autoimmune disease. Ask specifically about quantitative immunoglobulin levels if your doctor orders "basic labs." IgG, IgA, and IgM are not included in a standard metabolic panel and must be requested separately.

If initial labs are normal but infections continue, request a referral to a clinical immunologist. The Immune Deficiency Foundation maintains a physician finder at primaryimmune.org.